Largest companies by total assets
total assets
| Company | Total assets | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 401 | $186.82M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 402 | $186.27M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 403 | $184.67M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 404 | $183.47M | Healthcare | Medical Devices | United States | Nasdaq |
| 405 | $183.14M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 406 | $182.76M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 407 | $182.62M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 408 | $181.63M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 409 | $181.06M | Healthcare | Medical Devices | United States | Nasdaq |
| 410 | $179.51M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 411 | $179.35M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 412 | $176.09M | Healthcare | Biotechnology | United States | Nasdaq |
| 413 | $175.74M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 414 | $173.70M | Healthcare | Biotechnology | United States | Nasdaq |
| 415 | $171.45M | Healthcare | Biotechnology | United States | Nasdaq |
| 416 | $166.35M | Healthcare | Medical Devices | United States | Nasdaq |
| 417 | $165.30M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 418 | $163.59M | Healthcare | Biotechnology | United States | Nasdaq |
| 419 | $163.58M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 420 | $163.45M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 421 | $160.82M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 422 | $159.58M | Healthcare | Medical Devices | United States | Nasdaq |
| 423 | $159.17M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 424 | $154.25M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 425 | $154.22M | Healthcare | Biotechnology | United States | Nasdaq |
| 426 | $153.58M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 427 | $152.01M | Healthcare | Medical Devices | United States | NYSE |
| 428 | $151.01M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 429 | $148.17M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 430 | $145.38M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 431 | $142.97M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 432 | $142.77M | Healthcare | Biotechnology | United States | Nasdaq |
| 433 | $142.26M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 434 | $141.69M | Healthcare | Medical Devices | United States | NYSE |
| 435 | $141.40M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 436 | $138.09M | Healthcare | Biotechnology | United States | Nasdaq |
| 437 | $137.02M | Healthcare | Medical Devices | United States | Nasdaq |
| 438 | $136.15M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 439 | $134.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 440 | $133.65M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 441 | $132.10M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 442 | $131.53M | Healthcare | Medical Devices | United States | Nasdaq |
| 443 | $128.35M | Healthcare | Biotechnology | — | Nasdaq |
| 444 | $127.62M | Healthcare | Pharmaceuticals | United States | NYSE |
| 445 | $127.31M | Healthcare | Biotechnology | United States | Nasdaq |
| 446 | $126.96M | Healthcare | Pharmaceuticals | — | Nasdaq |
| 447 | $126.71M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 448 | $126.09M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 449 | $125.92M | Healthcare | Biotechnology | United States | Nasdaq |
| 450 | $125.25M | Healthcare | Biotechnology | United States | Nasdaq |
| 451 | $125.13M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 452 | $124.57M | Healthcare | Medical Devices | United States | Nasdaq |
| 453 | $124.21M | Healthcare | Biotechnology | United States | Nasdaq |
| 454 | $124.13M | Healthcare | Pharmaceuticals | — | Nasdaq |
| 455 | $124.00M | Healthcare | Biotechnology | United States | Nasdaq |
| 456 | $121.66M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 457 | $120.14M | Healthcare | Biotechnology | United States | Nasdaq |
| 458 | $118.20M | Healthcare | Medical Devices | United States | Nasdaq |
| 459 | $116.01M | Healthcare | Biotechnology | United States | Nasdaq |
| 460 | $115.81M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 461 | $115.56M | Healthcare | Medical Devices | United States | Nasdaq |
| 462 | $114.97M | Healthcare | Medical Devices | United States | Nasdaq |
| 463 | $114.73M | Healthcare | Medical Devices | United States | Nasdaq |
| 464 | $113.14M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 465 | $112.85M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 466 | $112.09M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 467 | $111.32M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 468 | $110.34M | Healthcare | Biotechnology | United States | NYSE |
| 469 | $105.21M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 470 | $105.01M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 471 | $103.90M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 472 | $102.85M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 473 | $101.59M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 474 | $101.08M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 475 | $99.54M | Healthcare | Biotechnology | United States | Nasdaq |
| 476 | $99.48M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 477 | $99.11M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 478 | $99.09M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 479 | $98.36M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 480 | $98.06M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 481 | $97.70M | Healthcare | Medical Devices | United States | NYSE |
| 482 | $96.99M | Healthcare | Medical Devices | United States | Nasdaq |
| 483 | $96.98M | Healthcare | Medical Devices | United States | Nasdaq |
| 484 | $95.88M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 485 | $95.33M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 486 | $95.09M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 487 | $93.57M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 488 | $93.54M | Healthcare | Biotechnology | United States | Nasdaq |
| 489 | $93.43M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 490 | $92.28M | Healthcare | Medical Devices | United States | Nasdaq |
| 491 | $89.95M | Healthcare | Biotechnology | United States | NYSE |
| 492 | $87.73M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 493 | $87.59M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 494 | $86.74M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 495 | $82.07M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 496 | $81.68M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 497 | $81.46M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 498 | $80.50M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 499 | $76.87M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 500 | $76.31M | Healthcare | Pharmaceuticals | United States | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 751 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.